China AI/ML, Automation, and Capability Expansion Lead, Biotherapeutics and Genetic Medicine

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Biotherapeutics and Genetic Medicine (BGM) team at AbbVie is a critical discovery engine supporting our ambition to become the top biopharma company in the world. BGM China expands the team’s access to China’s rapidly advancing scientific and technology ecosystem, connecting differentiated external capabilities with global discovery priorities to accelerate the delivery of transformational large-molecule candidates to patients. Reporting to the Director of China Strategy BGM, the China AI/ML, Automation, and Capability Expansion Lead will identify, evaluate, and help translate China-based AI/ML, automation, and emerging technical capabilities into practical value for BGM. The role will prioritize biotherapeutic discovery applications—including antibody design, protein engineering, and discovery workflow automation—while assessing relevance to genetic medicine where appropriate. Working closely with global BGM teams, this lead will support technology learning, external diligence, and collaboration models that strengthen BGM’s future capability with AI/ML and automation. This individual will also work closely with other partner functions in the Discovery and Development organizations.

Scout and access potential China-based partners in AI/ML and automation, including both service providers and biotech companies, and coordinate with CIE on selected opportunities. Work closely with global BGM stakeholders to track and assess emerging AI/ML applications in biotherapeutic discovery, including antibody design, protein engineering, enzyme evolution, and data-enabled experimental optimization. Work closely with global BGM stakeholders to assess discovery-stage automation solutions and customized automation systems that can improve speed, quality, and throughput in priority workflows. Evaluate other China-based external technology platforms, service models, and technical partners for scientific quality, operational fit, scalability, and strategic relevance to BGM. Facilitate learning and technology translation from China-based external partners to the global BGM team and other partner functions in R&D. Contribute to external diligence activities related to scientific feasibility, execution risk, and capability fit. Maintain close communication and alignment with global stakeholders to translate internal requirements into external evaluation criteria, and to convert external learning into internal capability building. Work closely with the broader AbbVie partnership ecosystem as needed, including AI S&P, BD, S&E, TLC, and other relevant functions, to ensure alignment on external scouting, evaluation, and translation priorities.

Ph.D. with 5–10 years of industry experience or a master’s degree with 10–15 years of industry experience. An advanced degree is preferred. Background in life sciences, chemistry, computer science or a related discipline; With relevant industry experience in discovery technologies, or related biopharmaceutical R&D fields; direct experience in AI/ML-enabled discovery and laboratory automation is strongly preferred. Strong understanding of AI/ML methods, automation systems, data-enabled experimentation, or digital discovery workflows, with demonstrated ability to